Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 175

1.

A Comparison of the Nephrotoxicity of Low Doses of Cadmium and Lead.

Satarug S, Gobe GC, Ujjin P, Vesey DA.

Toxics. 2020 Mar 2;8(1). pii: E18. doi: 10.3390/toxics8010018.

2.

Moderate prenatal ethanol exposure in the rat promotes kidney cell apoptosis, nephron deficits, and sex-specific kidney dysfunction in adult offspring.

Akison LK, Probyn ME, Gray SP, Cullen-McEwen LA, Tep K, Steane SE, Gobe GC, Wlodek ME, Bertram JF, Moritz KM.

Anat Rec (Hoboken). 2020 Jan 27. doi: 10.1002/ar.24370. [Epub ahead of print]

PMID:
31984647
3.

Underlying Histopathology Determines Response to Oxidative Stress in Cultured Human Primary Proximal Tubular Epithelial Cells.

Khan MA, Wang X, Giuliani KTK, Nag P, Grivei A, Ungerer J, Hoy W, Healy H, Gobe G, Kassianos AJ.

Int J Mol Sci. 2020 Jan 15;21(2). pii: E560. doi: 10.3390/ijms21020560.

4.

Nontraditional (non-Western pharmaceutical) treatments for chronic kidney disease.

Gobe GC, Wojcikowski K.

Clin Nephrol. 2019 Dec 12. doi: 10.5414/CNP92S108. [Epub ahead of print]

PMID:
31829927
5.

A cost-effective three-dimensional culture platform functionally mimics the adipose tissue microenvironment surrounding the kidney.

Shen K, Vesey DA, Hasnain SZ, Zhao KN, Wang H, Johnson DW, Saunders N, Burgess M, Gobe GC.

Biochem Biophys Res Commun. 2020 Feb 12;522(3):736-742. doi: 10.1016/j.bbrc.2019.11.119. Epub 2019 Nov 29.

PMID:
31787234
6.

The Source and Pathophysiologic Significance of Excreted Cadmium.

Satarug S, Vesey DA, Ruangyuttikarn W, Nishijo M, Gobe GC, Phelps KR.

Toxics. 2019 Oct 18;7(4). pii: E55. doi: 10.3390/toxics7040055.

7.

Chronic exposure to cadmium is associated with a marked reduction in glomerular filtration rate.

Satarug S, Boonprasert K, Gobe GC, Ruenweerayut R, Johnson DW, Na-Bangchang K, Vesey DA.

Clin Kidney J. 2018 Nov 21;12(4):468-475. doi: 10.1093/ckj/sfy113. eCollection 2019 Aug.

8.

Role of leptin as a biomarker for early detection of renal cell carcinoma? No evidence from a systematic review and meta-analysis.

Perumal K, Huin WK, Yap NY, Ong TA, Gobe GC, Rajandram R.

Med Hypotheses. 2019 Aug;129:109239. doi: 10.1016/j.mehy.2019.109239. Epub 2019 May 20. Erratum in: Med Hypotheses. 2019 Oct;131:109284.

PMID:
31371068
9.

Protease-activated receptor 2 does not contribute to renal inflammation or fibrosis in the obstructed kidney.

Ma FY, Han Y, Ozols E, Chew P, Vesey DA, Gobe GC, Morais C, Lohman RJ, Suen JY, Johnson DW, Fairlie DP, Nikolic-Paterson DJ.

Nephrology (Carlton). 2019 Sep;24(9):983-991. doi: 10.1111/nep.13635. Epub 2019 Jul 31.

PMID:
31314137
10.

Limitations to the Therapeutic Potential of Tyrosine Kinase Inhibitors and Alternative Therapies for Kidney Cancer.

Kamli H, Li L, Gobe GC.

Ochsner J. 2019 Summer;19(2):138-151. doi: 10.31486/toj.18.0015. Review.

11.

Heavy metal imaging in fibrotic human kidney tissue using the synchrotron X-ray fluorescence microprobe.

Gobe GC, Mott SA, de Jonge M, Hoy WE.

Transl Androl Urol. 2019 May;8(Suppl 2):S184-S191. doi: 10.21037/tau.2019.03.15. Review.

12.

Biomarkers and the role of mast cells as facilitators of inflammation and fibrosis in chronic kidney disease.

Owens EP, Vesey DA, Kassianos AJ, Healy H, Hoy WE, Gobe GC.

Transl Androl Urol. 2019 May;8(Suppl 2):S175-S183. doi: 10.21037/tau.2018.11.03. Review.

13.

Patient-derived xenograft models to optimize kidney cancer therapies.

Patel A, Cohen S, Moret R, Maresh G, Gobe GC, Li L.

Transl Androl Urol. 2019 May;8(Suppl 2):S156-S165. doi: 10.21037/tau.2018.11.04. Review.

14.

Prostate specific membrane antigen (PSMA) expression in vena cava tumour thrombi of clear cell renal cell carcinoma suggests a role for PSMA-driven tumour neoangiogenesis.

Morgantetti G, Ng KL, Samaratunga H, Rhee H, Gobe GC, Wood ST.

Transl Androl Urol. 2019 May;8(Suppl 2):S147-S155. doi: 10.21037/tau.2019.04.10.

15.

Utility of cytokeratin 7, S100A1 and caveolin-1 as immunohistochemical biomarkers to differentiate chromophobe renal cell carcinoma from renal oncocytoma.

Ng KL, Ellis RJ, Samaratunga H, Morais C, Gobe GC, Wood ST.

Transl Androl Urol. 2019 May;8(Suppl 2):S123-S137. doi: 10.21037/tau.2018.11.02.

16.

Translational research in kidney disease.

Gobe GC.

Transl Androl Urol. 2019 May;8(Suppl 2):S121-S122. doi: 10.21037/tau.2019.05.11. No abstract available.

17.

Tumor size and postoperative kidney function following radical nephrectomy.

Ellis RJ, White VM, Bolton DM, Coory MD, Davis ID, Francis RS, Giles GG, Gobe GC, Neale RE, Wood ST, Jordan SJ.

Clin Epidemiol. 2019 May 6;11:333-348. doi: 10.2147/CLEP.S197968. eCollection 2019.

18.

Establishment of epithelial and fibroblast cell cultures and cell lines from primary renal cancer nephrectomies.

Yap NY, Ong TA, Morais C, Pailoor J, Gobe GC, Rajandram R.

Cell Biol Int. 2019 Jun;43(6):715-725. doi: 10.1002/cbin.11150. Epub 2019 May 6.

PMID:
31062478
19.

Incident Chronic Kidney Disease After Radical Nephrectomy for Renal Cell Carcinoma.

Ellis RJ, White VM, Bolton DM, Coory MD, Davis ID, Francis RS, Giles GG, Gobe GC, Marco DJT, Neale RE, Wood ST, Jordan SJ; IMPROVE Investigators.

Clin Genitourin Cancer. 2019 Jun;17(3):e581-e591. doi: 10.1016/j.clgc.2019.02.011. Epub 2019 Mar 15.

PMID:
30975606
20.

The inverse association of glomerular function and urinary β2-MG excretion and its implications for cadmium health risk assessment.

Satarug S, Vesey DA, Nishijo M, Ruangyuttikarn W, Gobe GC.

Environ Res. 2019 Jun;173:40-47. doi: 10.1016/j.envres.2019.03.026. Epub 2019 Mar 14.

PMID:
30889420

Supplemental Content

Loading ...
Support Center